Skip to content
Super promo!Reishi−40%71.40 zł119 zł (regular price)
Only 98 left at 71.40 zł, then 83.30 złSee Reishi →
Free delivery in Poland from 299 PLN

Chinese caterpillar fungus vs. Cordyceps militaris: which one is in your capsule

Cordyceps sinensis is a wild fungus from Tibet, almost absent from supplements. Cordyceps militaris is cultivated as fruiting bodies. How to read the label and not get misled by the name.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

5 min read

Chinese caterpillar fungus vs. Cordyceps militaris: which one is in your capsule
Contents

You search for "Chinese caterpillar fungus" or "Cordyceps sinensis" and land on a shop selling Cordyceps militaris instead. That's not a mislabel, it's a practical consequence of how the raw-material market actually works. At Aloha Fungi we work with Cordyceps militaris, so let's explain plainly why that's not a lesser substitute, just a different species with a different story.

What's the difference between Cordyceps sinensis and Cordyceps militaris?

Cordyceps sinensis (now classified as Ophiocordyceps sinensis) is a wild fungus that parasitizes moth larvae of the genus Thitarodes, growing exclusively on high-altitude meadows in Tibet, Nepal, and Yunnan province, above 3,000-4,000 meters. Cordyceps militaris is a separate species, cultivated commercially on grain substrate or in liquid culture, known for higher cordycepin content in its fruiting body.

These are two different biological organisms, not two varieties of the same fungus. The shared genus name "Cordyceps" is misleading, it suggests this is a question of quality or sourcing within one raw material, when it isn't.

Why is real sinensis almost absent from supplements?

Wild Cordyceps sinensis grows slowly, only in a narrow high-altitude band, and harvesting it is manual work done by collectors in the Himalayas, seasonal and limited by nature's own volume. Top-grade specimens can fetch tens of thousands of dollars per kilogram in China, making it a collector's commodity, not a mass-market supplement ingredient.

That's why what appears on many labels as "Cordyceps sinensis" or "CS-4" is, in practice, lab-cultivated mycelium of the Cs-4 strain, scientifically identified as Paecilomyces hepiali, an organism related to but taxonomically distinct from wild sinensis. It's fermented mycelium grown on substrate, not a fruiting body harvested in the mountains.

What does "fruiting body" mean for Cordyceps?

The fruiting body is the visible, mature part of the fungus, the one that grows out of the larva's body in wild sinensis. Cordyceps militaris is one of the few Cordyceps species that can be commercially cultivated all the way to the fruiting-body stage, not just as mycelium on grain. At Aloha Fungi we work with a fruiting-body extract from C. militaris, standardized to over 0.3% cordycepin and over 30% β-glucans, described in more detail in our post on how Cordyceps works.

Verdict in one sentence (as of 13 September 2026): for everyday supplementation with a measurable cordycepin content, the best choice is a fruiting-body extract of Cordyceps militaris, because a cultivated fruiting body gives a repeatable profile that can be tested batch by batch; wild Cordyceps sinensis remains a choice for tradition and collectors, because its price and the lack of testing for any specific batch rule it out for everyday use. The batch passport YZKE10250208 for our Cordyceps (heavy metals and pesticides, Eurofins, March 2025) is on the Lab results page; for the "energy" goal we pair it with lion's mane in the ENERGIA duo.

How do you read the label so the species name doesn't mislead you?

Before you buy a product marketed as "Chinese caterpillar fungus," check four things on the label.

CheckWhat it means
Latin nameCordyceps militaris or Cordyceps sinensis/Ophiocordyceps sinensis, a different raw material
Fruiting body vs. myceliumFruiting body is the mature fungus, mycelium (e.g. Cs-4) is a substrate-grown culture
Cordycepin contentStated in mg or % standardization, not just "rich in"
Price per packageReal wild sinensis priced like an ordinary supplement is a warning sign

A label reading "Cordyceps sinensis Cs-4" isn't dishonest if the producer states clearly that it's mycelium of the Cs-4 strain, not wild raw material from Tibet. The problem starts where that distinction gets blurred and the package photo suggests high-altitude meadows.

What does TCM tradition say about both species?

In traditional Chinese medicine, it's wild Cordyceps sinensis, known as dōng chóng xià cǎo ("winter worm, summer grass"), that's described in classical texts as a kidney and lung tonic, prized for centuries in Tibet and western China. Cordyceps militaris doesn't share that long history in classical formulas; it entered common use alongside the growth of commercial cultivation in the 20th century. That's a description of tradition and cultivation history, not a comparison of effectiveness, which the scientific literature doesn't settle either way.

FAQ: frequently asked questions

Is Cordyceps militaris a lesser version of sinensis? No, it's a different species with a different compound profile, most notably higher cordycepin content in the fruiting body. You can't call one "better" or "worse" without pointing to a specific compound and how it's measured.

Is a product labeled "Cordyceps sinensis Cs-4" a scam? Not necessarily, as long as the label clearly states it's mycelium of the Cs-4 strain (Paecilomyces hepiali), not a wild fruiting body from Tibet. It's worth checking, because the raw-material difference is real.

Why is wild Cordyceps sinensis almost never in supplements? Because it only grows on high-altitude Himalayan meadows, in limited, seasonal quantities, which makes it a very expensive, collector-grade raw material, not viable for mass supplement production.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Cordyceps in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

9

human studies

3

placebo-controlled RCTs

2000–2026

years of publication

  • Zhou J. et al., 2021

    C

    RCT, double-blind, placebo-controlled

    59 people

    The study examined Cordyceps militaris as an add-on to duloxetine for insomnia associated with depression, in a group of 59 people, using a double-blind, placebo-controlled RCT design.

    PMID 34858228
  • Ontawong A. et al., 2024

    C

    RCT

    40 healthy adults

    The study examined the effect of a Cordyceps militaris beverage on immune response in 40 healthy adults, using an RCT design.

    PMID 38580687
  • Dubhashi S. et al., 2023

    C

    RCT, double-blind, placebo-controlled

    65 enrolled, 58 evaluated

    The study examined Cordyceps militaris in mild-to-moderate COVID-19, using a double-blind, placebo-controlled RCT, with 65 people enrolled (58 evaluated).

    PMID 37727187
  • Yang E.-J. et al., 2026

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The narrative review collected in vitro, in vivo and clinical data on Cordyceps militaris.

    PMID 41432716
  • Shu M.-Y. et al., 2025

    B

    systematic review with meta-analysis

    14 RCTs, 528 athletes

    The systematic review with meta-analysis collected 14 RCTs (528 athletes) on functional mushroom supplementation in athletes; the review covers multiple mushroom species at once, not only Cordyceps militaris.

    PMID 41280379
  • Choi E. et al., 2020

    E

    animal study (mice) · preclinical studies (in vitro and rodent)

    not applicable

    The mouse study examined the effect of Cordyceps militaris on physical performance.

    PMID 33312018
  • Hirsch K.R. et al., 2017

    C

    RCT, double-blind, placebo-controlled (mushroom blend, not an isolated species)

    28 (acute phase), 10 (chronic phase)

    The study examined the effect of a mushroom blend containing C. militaris (4 g/day) on VO2max, time to exhaustion, ventilatory threshold and power in a cycle ergometer test, using 1-week and 3-week protocols in trained adults. Limitations: n=10 in the chronic phase, a multi-ingredient preparation not isolating the species.

    PMID 27408987
  • Jędrejko M. et al., 2026

    E

    narrative review of human studies · preclinical studies (in vitro and rodent)

    5 studies, 321 participants aged 16-35

    The narrative review collected 5 intervention studies (2017-2024) on ergogenic effects and post-exercise recovery with supplementation in humans. Small samples, heterogeneous participants and protocols, incomplete randomisation reporting, most studies not registered.

    PMID 41829950
  • Tuli H.S. et al., 2014

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed the pharmacological potential of the genus Cordyceps, with particular focus on cordycepin, based on in vitro/in vivo data.

    DOI 10.1007/s13205-013-0121-9
  • Olatunji O.J. et al., 2018

    E

    narrative review (whole genus Cordyceps) · preclinical studies (in vitro and rodent)

    not applicable

    The review collected traditional uses, phytochemistry and pharmacology of the entire genus Cordyceps without separating species.

    PMID 29775778
  • Du J. et al., 2021

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The paper discussed mechanisms of cordycepin interaction with adenosine receptors and hypothetically linked this to brain protection and COVID-19. Purely theoretical, with no original data.

    DOI 10.26502/jbb.2642-91280035
  • Ko K.M., Leung H.Y., 2007

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed TCM tonic herbs (Cordyceps as one of several) in the context of ATP, antioxidation and immunomodulation. Does not isolate Cordyceps.

    PMID 17386115
  • Chen S. et al., 2010

    D

    pilot RCT

    20 enrolled, 15 completed

    The pilot randomised study examined the effect of the Cs-4 preparation (a fermented Cordyceps sinensis product) on physical performance in older adults, 20 enrolled, 15 completed.

    PMID 20804368
  • Parcell A.C. et al., 2004

    C

    RCT, double-blind

    22 cyclists

    The double-blind RCT examined the effect of the CordyMax Cs-4 preparation (Cordyceps sinensis) on performance in 22 cyclists.

    PMID 15118196
  • Yu X. et al., 2019

    B

    systematic review with meta-analysis

    14 RCTs, 1192 people

    The systematic review with meta-analysis collected 14 RCTs (1192 people) on Cordyceps sinensis in stable chronic obstructive pulmonary disease (COPD).

    PMID 31073318
  • Wu F. et al., 2025

    B

    systematic review with meta-analysis of RCTs

    15 RCTs, 1310 people

    The meta-analysis collected RCTs on oral Cordyceps sinensis as adjunct therapy in patients with renal dysfunction (creatinine, oliguria duration, urine osmolality). Small samples, short observation periods, predominance of studies from China.

    PMID 39839641
  • Kumar R. et al., 2011

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined exercise endurance capacity and skeletal muscle metabolic regulators after Cordyceps sinensis administration.

    PMID 21549819
  • Chiou W.F. et al., 2000

    E

    animal (rats) + in vitro (aorta) · preclinical studies (in vitro and rodent)

    not applicable

    The study in anaesthetised rats and isolated aortic rings examined the effect of a Cordyceps sinensis protein fraction on arterial pressure (intravenous administration) and vascular relaxation. Animal model, intravenous administration, does not translate to an oral supplement.

    PMID 10755473

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™